Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Evidence for the management of chronic obstructive pulmonary disease (COPD) comes from closely monitored efficacy trials involving groups of patients who were selected on the basis of restricted entry criteria. There is a need for randomized trials to be conducted in conditions that are closer to usual clinical practice.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): N. Engl. J. Med.

Title: The New England journal of medicine

Publisher: New England Journal of Medicine (NEJM/MMS)

ISSN (Electronic): 1533-4406

ISSN (Print): 0028-4793

Publication date (Electronic): September 29 2016

Volume: 375

Issue: 13

Affiliations

[1 ] From the Centre for Respiratory Medicine and Allergy, Manchester Academic Health Sciences Centre, University of Manchester and University Hospital of South Manchester NHS Foundation Trust (J.V., A.W.), Manchester Academic Health Sciences Centre, University of Manchester and Salford Royal NHS Foundation Trust (J.M.G.), and NIHR Clinical Research Network Greater Manchester (S.M.), Manchester; Global Respiratory Franchise (D.L.) and Respiratory Research and Development (S.C., J.C., L.F., H.S.), GlaxoSmithKline UK, Brentford; Salford Royal NHS Foundation Trust (N.D.B., J.N., J.M.G.), NorthWest EHealth (J.N., J.M.G.), and NHS Salford Clinical Commissioning Group (S.M.), Salford; and Global Clinical Safety and Pharmacovigilance, Safety Evaluation and Risk Management, GlaxoSmithKline UK, Uxbridge (C.H.) - all in the United Kingdom.

Article

DOI: 10.1056/NEJMoa1608033

PubMed ID: 27593504

SO-VID: 27dab06c-3357-44fe-9546-7d56605a1144

History

Data availability:

Comments

Comment on this article

scite_

Cited by 83

See all cited by